Slide 1: Presentation Q3 Report 2021
Presentation Q3 Report 2021 “Strong order growth and our remediation measures completed in Germany” Mattias Perjos, President & CEO Lars Sandström, CFO October 20, 2021
Slide 2: Key takeaways – a strong quarter from a financial perspective
Key takeaways – a strong quarter from a financial perspective Q3 2021 • Strong organic order growth • Net sales down vs record Q3 2020 • Adj EBITA margin 18.4% • Strong Free Cash Flow • Solid financial position 53.0 19.0 27,901 52 25,000 15 0 0 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020
Slide 3: Key activities and events
Key activities and events Q3 2021 Strengthening the offering further The improvement journey continues • Launch of Rotaflow II for ECMO-therapy • Remediation measures completed in Germany • Launch of the unique Volista VisioNIR- • Capacity increase in Life Science is progressing functionality for su
Slide 4: Strong organic order growth in Q3
Strong organic order growth in Q3 In all Business Areas and regions Global Americas EMEA APAC Organic Order Growth +21.8% Organic Net Sales Growth -20.1% Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 4
Slide 5: Outlook 2021
Outlook 2021 Net sales is expected to be at least 27 BSEK Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 5
Slide 6: Strong organic order growth in all Business Areas
Strong organic order growth in all Business Areas Order Intake – Bridge Q3 2020 – Q3 2021 Organic change +18.6% +29.6% +24.6% +21.8% 432 204 545 7,079 6,678 5,898 MSEK Q3 2019 Q3 2020 Acute Care Life Science Surgical Q3 2021 Therapies Workflows Getinge │ Presentation │ Q3 Report 2021 October 20, 202
Slide 7: Life Science grows net sales by 17.5% organically
Life Science grows net sales by 17.5% organically Net Sales – Bridge Q3 2020 – Q3 2021 Organic change -31.6% +17.5% -2.9% -20.1% 120 - 77 Currency impact, MSEK -1,718 -73 MSEK 7.8 7,976 6,236 6,306 Organic growth, % Q3 2019 Q3 2020 Acute Care Life Science Surgical Q3 2021 -41.2 Therapies Workflows C
Slide 8: Margin improvement in Life Science and Surgical Workflows
Margin improvement in Life Science and Surgical Workflows Adjusted Gross Profit – Bridge Q3 2020 – Q3 2021 Adj GM, % Q3 2021 60.7 44.3 41.7 52.9 (Q3 2020) (62.4) (42.6) (39.0) (54.9) (Q3 2019) (57.4) (40.4) (43.3) (50.8) Gross Margin impact 66 22 -1,132 Volume MSEK 4,378 Product mix 3,171 3,334 Fact
Slide 9: Financial development
Financial development Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 9
Slide 10: Adj EBITA down vs Q3 2020 but up more than 70% vs Q3 2019
Adj EBITA down vs Q3 2020 but up more than 70% vs Q3 2019 Adjusted EBITA – Bridge Q3 2020 – Q3 2021 Margin development -1.9 pp GP 25.4% 18.4% -3.5 pp OPEX -0.8 pp D&A -0.8 pp Currency -868 - 64 Currency impact, MSEK 36 39 33 9 MSEK 59 2,028 -1,044 1,160 677 Q3 2019 Q3 2020 Adj Gross Adj Selling Adj
Slide 11: Strong free cash flow and good control of working capital
Strong free cash flow and good control of working capital Continued efficiency enhancements Strong Free Cash Flow WC days well below 100 High Return on Invested Capital 140 Reduction 130 of -39 days 120 110 18.8% 2.3 2.0 100 1.6 1.4 90 1.2 7.5% 0 Q2 2018 Q2 2019 Q2 2020 Q2 2019 Q2 2020 Q3 2020 Q4 20
Slide 12: Solid financial position
Solid financial position Strengthened even further Improved net debt … … and leverage 14.0 3.4x 4.1 0.6x (0.1x excluding pension liabilities) Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 2021 Q2 2021 Q3 2021 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 202
Slide 13: Summary
Summary Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 13
Slide 14: Key takeaways
Key takeaways Summary Q3 2021 • Strong organic order growth • Good activity level and progress on strategy implementation • EBITA margin adjusted for Covid-19 continues to improve • Solid financial position Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 14
Slide 15: Q&A
Q&A Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 15
Slide 16: Thank you
Thank you Getinge │ Presentation │ Q3 Report 2021 October 20, 2021 Page 16
Slide 17: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Slide 18: Getinge – Passion for Life
Se a GETINGE PASSION FOR LIFE